Mass testing for covid-19 in the UK

@article{Gill2020MassTF,
  title={Mass testing for covid-19 in the UK},
  author={Mike W Gill and Muir Gray},
  journal={BMJ},
  year={2020},
  volume={371}
}
An unevaluated, underdesigned, and costly mess 

Covid-19: Concerns persist about purpose, ethics, and effect of rapid testing in Liverpool

The government is hailing Liverpool’s testing pilot as a great success and plans to offer rapid lateral flow tests to other areas with high rates of covid-19. But the scheme raises more questions

Covid-19: Screening without scrutiny, spending taxpayers’ billions

TLDR
It is screening by the back door, bypassing appraisal by the UK's National Screening Committee, and the lateral flow test being used is of doubtful value, with a high false negative rate.

Covid-19 mass testing: throwing the baby out with the bathwater?

TLDR
The BMJ should campaign for Operation Moonshot to be improved during rollout rather than stopped, and the government’s unevaluated coronavirus mass testing plan and the appointment of commercial consultants and contractors with little relevant expertise to design and run it should be improved.

Discourse on COVID-19 Mass Testing vs. Rapid Testing Processing

COVID-19 “mass testing” and “rapid processing” are often mistaken as one process. While the two are correlated and partly overlapping each other, they are different in terms of processing and

Modelling pooling strategies for SARS-CoV-2 testing in a university setting

TLDR
This study presents a simulation framework to evaluate the effectiveness of different asymptomatic testing strategies within a university setting, across a range of transmission scenarios, and shows that when positive cases are clustered by known social structures, the pooling of samples by these social structures can substantially reduce the total cost of conducting RT-qPCR tests.

Rapid antigenic tests to detect asymptomatic covid-19 infections

  • J. Turabián
  • Medicine
    Archives of Community Medicine and Public Health
  • 2021
Coronavirus disease 2019 (COVID-19) is a new disease, and obviously many things about it are not yet known for sure. But, the evolution of knowledge about it is being very fast.

Assessment of the National Test Strategy on the Development of the COVID-19 Pandemic in Denmark

TLDR
The Danish mass testing strategy for CO VID-19 does not appear to have a detectable correlation to the number of hospitalizations due to COVID-19, and the relationship between positives in antigen testing and in rt-PCR testing indicated that many patients were not tested early in their infection when the risk of transmission was at the highest.

Feasibility and Acceptability of community COVID-19 Testing Strategies (FACTS) in a University setting

TLDR
It is found that self-testing is acceptable and people were able to interpret results accurately in the SARS-CoV-2 testing programme, and there were concerns about test accuracy that impacted uptake and adherence.

A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

TLDR
Efficient management of resources for the policy of mass screening in asymptomatic populations can generate high social returns and the monetization of health is the critical element that tips the scales in favour of the desirability of screening.

When is a screening test not a screening test?

  • J. Ashton
  • Medicine
    Journal of the Royal Society of Medicine
  • 2021
TLDR
The COVID-19 pandemic of 2019-2020 took governments around the world by surprise, and despite all the failings of political and practical public health action of the early months, the international academic community and industry, particularly bio pharma and med-tech, were galvanised into action.

References

SHOWING 1-10 OF 11 REFERENCES

Covid-19: breaking the chain of household transmission

TLDR
The authors urgently need new measures to protect household contacts from cyber-bullying, according to the World Health Organization.

Screening the healthy population for covid-19 is of unknown value, but is being introduced nationwide

Concerns this will see demolition of hard won frameworks for protecting the public from ineffective, poorly delivered, and unethically practised screening

Covid-19: Government plans to spend £100bn on expanding testing to 10 million a day

TLDR
The leaked documents reveal a heavy reliance on the private sector to achieve the mass testing and give details of “letters of comfort” that have already been signed with companies to reach three million tests a day by December.

The inverse care law.

Adherence to the test, trace and isolate system: results from a time series of 21 nationally representative surveys in the UK (the COVID-19 Rapid Survey of Adherence to Interventions and Responses study)

TLDR
Non-adherence was associated with: men, younger age groups, having a dependent child in the household, lower socio-economic grade, greater hardship during the pandemic, and working in a key sector.

Population healthcare: designing population-based systems

  • M. Gray
  • Medicine
    Journal of the Royal Society of Medicine
  • 2017
The right structure is useful for simple tasks, but most health and healthcare issues are complex, where complexity is defined as ‘the dynamic state between order and chaos’. This means there is no

Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis

TLDR
AsymPTomatic COVID‐19 patients could have abnormal laboratory and radiational manifestations, which can be used as screening strategies to identify asymptomatic infection.

NHS test and trace chief admits workers fear "financial" hit if they self-isolate

  • Huffington Post

University of Oxford SARS-CoV-2 test development and validation cell: rapid evaluation of lateral flow viral antigen detection devices (LFDs) for mass community testing

  • Preliminary report from the Joint PHE Porton Down &

UK Standards for Public Involvement